MoonLake Immunotherapeutics, (MLTX) Social Stream
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Price Targets From Analysts
Use the tables below to see what analysts covering MOONLAKE IMMUNOTHERAPEUTICS think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-15 | 2 | $28 | $28 | $28 | $55.96 | -49.96% |
| 2022-09-12 | 3 | $28 | $17 | $22.5 | $55.96 | -59.79% |
| 2022-12-14 | 4 | $28 | $16 | $20.333 | $55.96 | -63.67% |
| 2023-02-13 | 5 | $28 | $16 | $21.5 | $55.96 | -61.58% |
| 2023-03-06 | 6 | $28 | $16 | $21.8 | $55.96 | -61.04% |
| 2023-03-20 | 7 | $36 | $16 | $24.166 | $55.96 | -56.82% |
| 2023-03-21 | 8 | $36 | $16 | $27 | $55.96 | -51.75% |
| 2023-03-22 | 8 | $36 | $16 | $27.857 | $55.96 | -50.22% |
| 2023-03-24 | 8 | $36 | $25 | $29.857 | $55.96 | -46.65% |
| 2023-05-04 | 8 | $36 | $25 | $30.142 | $55.96 | -46.14% |
| 2023-05-15 | 8 | $37 | $25 | $31.142 | $55.96 | -44.35% |
| 2023-05-29 | 8 | $37 | $28 | $32.714 | $55.96 | -41.54% |
| 2023-06-15 | 9 | $37 | $28 | $32.125 | $55.96 | -42.59% |
| 2023-06-26 | 10 | $61 | $28 | $45.625 | $55.96 | -18.47% |
| 2023-06-27 | 10 | $68 | $29 | $52.777 | $55.96 | -5.69% |
| 2023-07-03 | 10 | $68 | $37 | $56.777 | $55.96 | 1.46% |
| 2023-07-26 | 10 | $75 | $41 | $61 | $55.96 | 9.01% |
| 2023-08-10 | 10 | $86 | $41 | $63.777 | $55.96 | 13.97% |
| 2023-08-14 | 10 | $86 | $41 | $64.777 | $55.96 | 15.76% |
| 2023-08-31 | 11 | $86 | $41 | $65.9 | $55.96 | 17.76% |
| 2023-09-12 | 11 | $86 | $41 | $69.2 | $55.96 | 23.66% |
| 2023-10-17 | 11 | $86 | $59 | $71 | $55.96 | 26.88% |
| 2023-10-26 | 11 | $86 | $59 | $73.4 | $55.96 | 31.17% |
| 2023-11-07 | 12 | $86 | $59 | $73.454 | $55.96 | 31.26% |
| 2023-11-08 | 12 | $86 | $55 | $71.181 | $55.96 | 27.2% |
| 2023-11-16 | 12 | $92 | $55 | $71.1 | $55.96 | 27.06% |
| 2023-12-08 | 13 | $92 | $55 | $72.272 | $55.96 | 29.15% |
| 2023-12-18 | 13 | $92 | $55 | $72.545 | $55.96 | 29.64% |
The Trend in the Analyst Price Target
Over the past 175 days, MLTX's average price target has gone up $26.92.
Over the past 45 weeks, MLTX's average upside potential has been 29.66%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-24 | 8 | 36 | 25 | 29.857 | 21.02 | 42.04% |
| 2023-05-04 | 8 | 36 | 25 | 30.142 | 24.56 | 22.73% |
| 2023-05-10 | 8 | 37 | 25 | 31.142 | 28.24 | 10.28% |
| 2023-11-03 | 12 | 86 | 59 | 73.454 | 51.28 | 43.24% |
| 2023-11-08 | 12 | 86 | 55 | 70.500 | 40.18 | 75.46% |
MLTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.23 | 11 | 1 | 1 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 31 weeks, MLTX's average broker recommendation rating worsened by 0.23.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MLTX as an investment opportunity.
- MLTX has a higher upside potential (average analyst target price relative to current price) than 867.68% of all US stocks.
- In terms of how MOONLAKE IMMUNOTHERAPEUTICS fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 2123.37% of that group.
- In terms of how MOONLAKE IMMUNOTHERAPEUTICS fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 1993.97% of that group.
- In the context of stocks in the mid market cap category, MOONLAKE IMMUNOTHERAPEUTICS's variance in analysts' estimates is lower than -1983.07% of them.
Stocks similar to MOONLAKE IMMUNOTHERAPEUTICS in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ERAS, NUVL, and VTYX.
View All Top Stocks by Price Target
What is the outlook for MLTX? Use POWR Ratings for clearer insight into price direction.